Health care startups that raised Series D or later in North America
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Zipline International | South San Francisco | Series I | $1.5B | 2026-11-05 |
| Pathos | New York | Series E | $237.0M | 2026-10-23 |
| Sirona Medical | San Francisco | Series D | $40.0M | 2026-10-15 |
| Suki | Redwood City | Series E | $90.0M | 2026-10-12 |
| EliseAI | New York | Series F | $350.0M | 2026-09-29 |
| Rightway | New York | Series E | $155.0M | 2026-09-24 |
| OpenEvidence | Miami | Series E | $250.0M | 2026-09-16 |
| Circle Pharma | South San Francisco | Series E | $92.5M | 2026-09-16 |
8 rows of the CSV in 5 of its 18 columns.
- The 444 health care startups in North America whose last round is Series D or later have raised $82.2B in total.
- 57 of them closed their most recent round in the last 12 months, $8.4B combined.
- The largest of those rounds is Zipline International's $1.5B Series I, dated November 2026.
- Khosla Ventures is an investor in 9 of them, more than any other fund.
- Biotech is the most common other sector, with 217 companies (49%).
- 3% were founded in 2020 or later; the median founding year is 2009.
- The most common team size is 11 to 50 employees (28% of companies with a recorded size).
- 20 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 444| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | South San Francisco, United States | Series I | $1.5B | 2026-11-05 | $3.6B | Techstars, Andreessen Horowitz, Sequoia Capital +2 | 1,001 to 5,000 | 2011 |
| Pathos | Pathos is a biotechnology company that uses AI to speed up oncology drug development. | Artificial intelligence | New York, United States | Series E | $237.0M | 2026-10-23 | $684.0M | New Enterprise Associates, Lightbank, Builders VC +1 | 11 to 50 | 2022 |
| Sirona Medical | Sirona Medical develops cloud-native radiology workflow software for medical imaging practices. | Artificial intelligence | San Francisco, United States | Series D | $40.0M | 2026-10-15 | $144.5M | Global Founders Capital, 8VC, GreatPoint Ventures +2 | 101 to 250 | 2018 |
| Suki | Suki builds AI tools that help clinicians with clinical documentation and administrative tasks. | Artificial intelligence | Redwood City, United States | Series E | $90.0M | 2026-10-12 | $255.0M | Gaingels, First Round Capital, Breyer Capital +2 | 251 to 500 | 2017 |
| EliseAI Unicorn | EliseAI provides AI-driven automation that manages workflows for housing and healthcare operations. | Artificial intelligence | New York, United States | Series F | $350.0M | 2026-09-29 | $741.9M | Point72 Ventures, Golden Seeds, Navitas Capital +1 | 101 to 250 | 2017 |
| Rightway Unicorn | Rightway provides a health technology service that lowers healthcare costs and improves patient outcomes. | Health care | New York, United States | Series E | $155.0M | 2026-09-24 | $394.3M | Tiger Global Management, Khosla Ventures, Thrive Capital +2 | 501 to 1,000 | 2017 |
| OpenEvidence | OpenEvidence builds a medical AI search engine that helps clinicians make evidence-based decisions. | Artificial intelligence | Miami, United States | Series E | $250.0M | 2026-09-16 | $1.0B | Sequoia Capital | 11 to 50 | 2021 |
| Circle Pharma | Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. | Biotech | South San Francisco, United States | Series E | $92.5M | 2026-09-16 | $300.0M | Mission BioCapital, Pfizer, The Column Group +1 | 11 to 50 | 2012 |
| Alzheon | Alzheon develops treatments for neurodegenerative disorders as a clinical-stage biotechnology company. | Biotech | Framingham, United States | Series F | $78.8M | 2026-09-10 | $343.3M | Ally Bridge Group, National Institute on Aging | 11 to 50 | 2013 |
| Thyme Care | Thyme Care provides value-based oncology management that coordinates care for people diagnosed with cancer. | Health care | Nashville, United States | Series E | $125.0M | 2026-09-02 | $399.0M | Andreessen Horowitz, Bessemer Venture Partners, Casdin Capital +2 | 501 to 1,000 | 2020 |
| Hopscotch Primary Care | Hopscotch Primary Care provides healthcare services to rural communities across the country. | Health care | Chicago, United States | Series D | $53.0M | 2026-08-18 | $103.0M | Alumni Ventures, 8VC, Town Hall Ventures +2 | 101 to 250 | 2021 |
| Craif | Craif develops a cancer diagnosis algorithm using microRNA data and machine learning. | Artificial intelligence | Irvine, United States | Series D | $24.4M | 2026-08-18 | $68.7M | Global Brain Corporation, VentureOut, ANRI +1 | 51 to 100 | 2018 |
| Petfolk | Petfolk provides in-person and virtual veterinary care for pets. | Health care | Charlotte, United States | Series D | $40.0M | 2026-08-13 | $156.0M | White Star Capital, TriplePoint Capital, Idea Farm Ventures +1 | 101 to 250 | 2020 |
| Lycia Therapeutics | Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. | Biotech | South San Francisco, United States | Series D | $75.0M | 2026-06-25 | $301.6M | Franklin Templeton, Alexandria Venture Investments, Invus +1 | 11 to 50 | 2019 |
| Element Biosciences Unicorn | Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. | Biotech | San Diego, United States | Series E | $277.0M | 2026-06-09 | $678.0M | RA Capital Management, Fidelity, Wellington Management +2 | 251 to 500 | 2017 |
| Cagent Vascular | Cagent Vascular develops serration technology to improve treatment of cardiovascular disease. | Health care | Wayne, United States | Series D | $41.0M | 2026-05-19 | $107.9M | U.S. Venture Partners, Ben Franklin Technology Partners of Southeastern Pennsylvania, Ben Franklin Technology Partners +2 | 51 to 100 | 2014 |
| Calyxo | Calyxo is a medical device company that develops urology technologies for kidney stone treatment. | Health care | Pleasanton, United States | Series F | $40.0M | 2026-04-14 | $165.4M | Questa Capital Management, Avidity Partners | 251 to 500 | 2016 |
| Chapter | Chapter offers a Medicare navigation platform with advisory services for seniors seeking health coverage. | Fintech | New York, United States | Series E | $100.0M | 2026-04-09 | $284.0M | Susa Ventures, XYZ Venture Capital, Maverick Ventures +1 | 101 to 250 | 2013 |
| Click Therapeutics | Click Therapeutics develops and commercializes software-based prescription treatments for unmet healthcare needs. | Biotech | New York, United States | Series D | $50.0M | 2026-04-09 | $1.1B | Silicon Valley Bank, Accelmed, HSBC Innovation Banking +1 | 101 to 250 | 2012 |
| WHOOP Unicorn | WHOOP sells wearable fitness devices and a subscription service that tracks physiological data for performance insights. | Hardware | Boston, United States | Series G | $575.0M | 2026-03-31 | $979.8M | Founder Collective, SoftBank Vision Fund, Foundry Group +2 | 501 to 1,000 | 2012 |
| Avation Medical | Avation Medical develops non-invasive neuromodulation devices that treat gastrointestinal disorders. | Hardware | Columbus, United States | Series D | $22.0M | 2026-03-20 | $34.9M | Arboretum Ventures, JobsOhio, Avestria Ventures | 101 to 250 | 2016 |
| Numerion Labs | Numerion Labs develops artificial intelligence systems for drug discovery using deep learning algorithms. | Artificial intelligence | San Francisco, United States | Series D | $19.8M | 2026-03-19 | $241.4M | Y Combinator, Khosla Ventures, Creative Destruction Lab +1 | 11 to 50 | 2012 |
| Vestwell Unicorn | Vestwell is a digital savings platform that offers and manages savings and retirement plans. | Fintech | New York, United States | Series E | $385.0M | 2026-02-18 | $623.8M | Goldman Sachs, Point72 Ventures, Franklin Templeton +2 | 501 to 1,000 | 2016 |
| Varda | Varda manufactures products in microgravity in space and returns them to Earth for use. | Health care | El Segundo, United States | Series D | $275.0M | 2026-02-17 | $603.1M | General Catalyst, Khosla Ventures, Founders Fund +2 | 101 to 250 | 2021 |
| Talkiatry | Talkiatry provides insurance-covered virtual mental healthcare, connecting patients with licensed psychiatrists. | Health care | New York, United States | Series D | $210.0M | 2026-02-12 | $452.0M | Andreessen Horowitz, Left Lane Capital, Perceptive Advisors +1 | 501 to 1,000 | 2019 |
| Angitia Biopharmaceuticals | Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases. | Biotech | Westlake Village, United States | Series D | $130.0M | 2026-02-05 | $406.0M | Legend Capital, OrbiMed, Oriza Holdings +1 | 51 to 100 | 2018 |
| Midi Health | Midi Health provides virtual care for women in midlife, including menopause and hormonal health support. | Health care | Palo Alto, United States | Series D | $100.0M | 2026-02-03 | $252.0M | Google Ventures, City Light Capital, Icon Ventures | 101 to 250 | 2021 |
| Artera | Artera provides AI-powered virtual agents that handle voice and text communication for patient care. | Artificial intelligence | Santa Barbara, United States | Series D | $65.0M | 2025-12-03 | $110.1M | Techstars, Freestyle Capital, Jackson Square Ventures +2 | 251 to 500 | 2015 |
| Synchron | Synchron develops neuromodulation solutions for nervous system conditions previously untreatable. | Health care | Brooklyn, United States | Series D | $200.0M | 2025-11-06 | $330.0M | Alumni Ventures, Khosla Ventures, ARCH Venture Partners +1 | 101 to 250 | 2016 |
| Elucid | Elucid applies AI to medical images to support precision medicine for cardiovascular disease. | Biotech | Boston, United States | Series D | $36.5M | 2025-10-22 | $166.2M | National Science Foundation, Sand Hill Angels, IAG Capital Partners +1 | 101 to 250 | 2013 |
Table 1. Health care startups that raised Series D or later in North America: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 444.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | South San Francisco, United States | Series I | $1.5B | 2026-11-05 | $3.6B | Techstars, Andreessen Horowitz, Sequoia Capital +2 | 1,001 to 5,000 | 2011 |
| 2 | WHOOP Unicorn | WHOOP sells wearable fitness devices and a subscription service that tracks physiological data for performance insights. | Hardware | Boston, United States | Series G | $575.0M | 2026-03-31 | $979.8M | Founder Collective, SoftBank Vision Fund, Foundry Group +2 | 501 to 1,000 | 2012 |
| 3 | Vestwell Unicorn | Vestwell is a digital savings platform that offers and manages savings and retirement plans. | Fintech | New York, United States | Series E | $385.0M | 2026-02-18 | $623.8M | Goldman Sachs, Point72 Ventures, Franklin Templeton +2 | 501 to 1,000 | 2016 |
| 4 | EliseAI Unicorn | EliseAI provides AI-driven automation that manages workflows for housing and healthcare operations. | Artificial intelligence | New York, United States | Series F | $350.0M | 2026-09-29 | $741.9M | Point72 Ventures, Golden Seeds, Navitas Capital +1 | 101 to 250 | 2017 |
| 5 | Element Biosciences Unicorn | Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. | Biotech | San Diego, United States | Series E | $277.0M | 2026-06-09 | $678.0M | RA Capital Management, Fidelity, Wellington Management +2 | 251 to 500 | 2017 |
| 6 | Varda | Varda manufactures products in microgravity in space and returns them to Earth for use. | Health care | El Segundo, United States | Series D | $275.0M | 2026-02-17 | $603.1M | General Catalyst, Khosla Ventures, Founders Fund +2 | 101 to 250 | 2021 |
| 7 | OpenEvidence | OpenEvidence builds a medical AI search engine that helps clinicians make evidence-based decisions. | Artificial intelligence | Miami, United States | Series E | $250.0M | 2026-09-16 | $1.0B | Sequoia Capital | 11 to 50 | 2021 |
| 8 | Pathos | Pathos is a biotechnology company that uses AI to speed up oncology drug development. | Artificial intelligence | New York, United States | Series E | $237.0M | 2026-10-23 | $684.0M | New Enterprise Associates, Lightbank, Builders VC +1 | 11 to 50 | 2022 |
| 9 | Talkiatry | Talkiatry provides insurance-covered virtual mental healthcare, connecting patients with licensed psychiatrists. | Health care | New York, United States | Series D | $210.0M | 2026-02-12 | $452.0M | Andreessen Horowitz, Left Lane Capital, Perceptive Advisors +1 | 501 to 1,000 | 2019 |
| 10 | Rightway Unicorn | Rightway provides a health technology service that lowers healthcare costs and improves patient outcomes. | Health care | New York, United States | Series E | $155.0M | 2026-09-24 | $394.3M | Tiger Global Management, Khosla Ventures, Thrive Capital +2 | 501 to 1,000 | 2017 |
Table 2. Health care startups that raised Series D or later in North America: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Khosla Ventures | Venture capital firm | Menlo Park, United States | 9 | 2% | 3 | Rightway, Numerion Labs, Varda |
| 2 | Alumni Ventures | Angel group | Manchester, United States | 8 | 2% | 1 | Hopscotch Primary Care |
| 3 | General Catalyst | Venture capital firm | San Francisco, United States | 8 | 2% | 1 | Varda |
| 4 | Andreessen Horowitz | Venture capital firm | Menlo Park, United States | 7 | 2% | 3 | Zipline International, Thyme Care, Talkiatry |
| 5 | Thrive Capital | Startup incubator | New York, United States | 7 | 2% | 1 | Rightway |
| 6 | Google Ventures | Corporate venture arm | San Francisco, United States | 7 | 2% | 1 | Midi Health |
| 7 | OrbiMed | Private equity firm | New York, United States | 6 | 1% | 1 | Angitia Biopharmaceuticals |
| 8 | Sequoia Capital | Venture capital firm | Menlo Park, United States | 5 | 1% | 2 | Zipline International, OpenEvidence |
| 9 | New Enterprise Associates | Venture capital firm | Menlo Park, United States | 5 | 1% | 1 | Pathos |
| 10 | First Round Capital | Venture capital firm | Philadelphia, United States | 5 | 1% | 1 | Suki |
| 11 | Tiger Global Management | Hedge fund | New York, United States | 5 | 1% | 1 | Rightway |
| 12 | MedTech Innovator | Startup accelerator | Los Angeles, United States | 5 | 1% | 1 | Craif |
| 13 | RA Capital Management | Startup incubator | Boston, United States | 5 | 1% | 1 | Element Biosciences |
| 14 | Techstars | Startup accelerator | New York, United States | 4 | 1% | 2 | Zipline International, Artera |
| 15 | Fidelity | Investment bank | Boston, United States | 4 | 1% | 2 | Zipline International, Element Biosciences |
Table 3. Health care startups that raised Series D or later in North America: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 217 | 49% | $34.3B |
| Software | 90 | 20% | $21.3B |
| Artificial intelligence | 38 | 9% | $12.2B |
| Hardware | 23 | 5% | $6.6B |
| Fintech | 9 | 2% | $3.0B |
| Commerce | 7 | 2% | $2.1B |
| Education | 2 | 0% | $82.5M |
| Cybersecurity | 2 | 0% | $166.9M |
Table 4. Health care startups that raised Series D or later in North America by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series D+ | 444 | 100% | $40.0M |
Table 5. Health care startups that raised Series D or later in North America by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| United States | 434 | 98% |
| Canada | 10 | 2% |
Table 6. Health care startups that raised Series D or later in North America by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| New York | 34 | 8% |
| San Francisco | 24 | 5% |
| San Diego | 19 | 4% |
| Redwood City | 14 | 3% |
| South San Francisco | 12 | 3% |
| Cambridge | 12 | 3% |
| Mountain View | 12 | 3% |
| Boston | 10 | 2% |
| Menlo Park | 8 | 2% |
| Irvine | 7 | 2% |
| Waltham | 7 | 2% |
| Palo Alto | 7 | 2% |
Table 7. Health care startups that raised Series D or later in North America by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 2 | 4% | $1.5B |
| October 2026 | 6 | 11% | $594.7M |
| September 2026 | 9 | 16% | $1.9B |
| August 2026 | 7 | 12% | $487.4M |
| July 2026 | 2 | 4% | $187.4M |
| June 2026 | 3 | 5% | $452.0M |
| May 2026 | 6 | 11% | $310.0M |
| April 2026 | 5 | 9% | $240.0M |
| March 2026 | 5 | 9% | $816.8M |
| February 2026 | 6 | 11% | $1.2B |
| January 2026 | 3 | 5% | $555.0M |
| December 2025 | 2 | 4% | $90.0M |
| November 2025 | 1 | 2% | $45.0M |
Table 8. Health care startups that raised Series D or later in North America: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 54 | 12% | $8.3B |
| 2025 | 40 | 9% | $4.2B |
| 2024 | 32 | 7% | $2.5B |
| 2023 | 19 | 4% | $1.6B |
| 2022 | 25 | 6% | $2.6B |
| 2021 | 45 | 10% | $5.5B |
Table 9. Health care startups that raised Series D or later in North America by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 14 | 3% |
| 2015 to 2019 | 95 | 21% |
| 2010 to 2014 | 106 | 24% |
| Before 2010 | 227 | 51% |
Table 10. Health care startups that raised Series D or later in North America by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 31 | 7% |
| 11 to 50 | 122 | 28% |
| 51 to 100 | 104 | 24% |
| 101 to 250 | 84 | 19% |
| 251 to 500 | 38 | 9% |
| 501 to 1,000 | 34 | 8% |
| 1,001 to 5,000 | 20 | 5% |
| 5,001 to 10,000 | 3 | 1% |
| 10,001 or more | 4 | 1% |
Table 11. Health care startups that raised Series D or later in North America by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series D or later and its headquarters is in North America. On 16 November 2026 that is 444 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 444 rows: 29 have no round amount, 0 no city and 36 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in North America whose last round is Series D or later are on the list?
- 444, in the file dated 16 November 2026. 57 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 444 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.